Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement Post author:GHIAA Admin Post published:June 8, 2022 Post category: Continue ReadingEntasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement Post author:GHIAA Admin Post published:June 8, 2022 Post category: Continue ReadingEntasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement Post author:GHIAA Admin Post published:June 8, 2022 Post category: Continue ReadingEntasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement Post author:GHIAA Admin Post published:June 7, 2022 Post category: Continue ReadingEntasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement Post author:GHIAA Admin Post published:June 7, 2022 Post category: Continue ReadingEntasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement Post author:GHIAA Admin Post published:June 7, 2022 Post category: Continue ReadingEntasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
CSIC – MPP (C-TAP), COVID-19 Diagnostic, Patent & Material License Agreement Post author:GHIAA Admin Post published:May 24, 2022 Post category: Continue ReadingCSIC – MPP (C-TAP), COVID-19 Diagnostic, Patent & Material License Agreement
CSIC – MPP (C-TAP), COVID-19 Diagnostic, Patent & Material License Agreement Post author:GHIAA Admin Post published:May 24, 2022 Post category: Continue ReadingCSIC – MPP (C-TAP), COVID-19 Diagnostic, Patent & Material License Agreement
CSIC – MPP (C-TAP), COVID-19 Diagnostic, Patent & Material License Agreement Post author:GHIAA Admin Post published:May 23, 2022 Post category: Continue ReadingCSIC – MPP (C-TAP), COVID-19 Diagnostic, Patent & Material License Agreement